Our business partner announced a new portfolio structure, rebranding, and transition from Asuragen to Bio-Techne.
This strategic rebranding emphasizes the expanded capabilities and renewed focus on delivering comprehensive solutions across the clinical diagnostics development spectrum. This includes high-quality components, bespoke development services, and fully regulatory-compliant IVD solutions.
Bio-Techne products and technologies will be organized into three distinct portfolio brands, reflecting the scientific journey from early discovery through translational insight to clinical decision-making:
- R&D Systems by Bio-Techne: Reagents, proteins, antibodies, and tools for early research.
- Bio-Techne Spatial: Solutions for biological and disease characterization, including RNAscope™ and COMET™ platforms.
- Bio-Techne Diagnostics: Assay kits and reagents for clinical labs and IVD manufacturers.
